Abstract submission is now closed
Abstract submission deadlines
Deadline |
Date and time |
|---|---|
|
Tuesday, 29 November 2022, 21:00hrs CET |
Outcome notifications
Outcome notifications are expected to be made available to first authors and submitters by 16 December 2022.
Information for presenters
Detailed instructions for the preparation of slide presentations and/or posters will be made available by mid-January 2023, in the section “Information for Presenters”.
Abstract submission categories
- Basic and translational research
- Cervical cancer
- Endometrial cancer
- Ovarian cancer
- General interest
Trial in Progress abstracts (TiP)
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Gynaecological Cancers Congress 2023.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Presentation and publication of accepted abstracts
The ESMO Gynaecological Cancers Congress 2023 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts will be published online in the ESMO Gynae 2023 Abstract Book, a supplement to ESMO Open.
Publication schedule for accepted abstracts
Details regarding the publication of accepted abstracts are available here.
Merit Travel Grants
A limited number of Merit Travel Grants to the ESMO Gynaecological Cancers Congress 2023 are available, upon application, to first authors under the age of 40 (forty) who submit abstracts considered deserving of recognition. Selection will be made by the ESMO Gynaecological Cancers 2023 Scientific Committee on a competitive basis from among the accepted abstracts.